Gan & Lee Pharmaceuticals. (SHA:603087)
58.10
-1.54 (-2.58%)
Jul 25, 2025, 2:45 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 34.79 billion as of July 25, 2025. Its market cap has increased by 25.80% in one year.
Market Cap
34.79B
Enterprise Value
32.44B
Revenue
3.47B
Ranking
n/a
PE Ratio
41.13
Stock Price
58.10
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 34.79B, a decrease of -4.86%. That is a compound annual growth rate of -0.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2025 | 34.79B | 32.14% |
Dec 31, 2024 | 26.33B | -15.24% |
Dec 29, 2023 | 31.07B | 68.57% |
Dec 30, 2022 | 18.43B | -53.34% |
Dec 31, 2021 | 39.50B | -46.80% |
Dec 31, 2020 | 74.25B | 103.01% |
Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 381.16B |
Shenzhen Mindray Bio-Medical Electronics | 276.35B |
WuXi AppTec | 239.63B |
Sichuan Biokin Pharmaceutical | 124.35B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.50B |
Aier Eye Hospital Group | 118.61B |
Shanghai United Imaging Healthcare | 109.45B |
Yunnan Baiyao Group Co.,Ltd | 100.86B |